Try our Advanced Search for more refined results

Generics Cos. Ask Fed. Circ. To Nix Pfizer's Lyrica Patent

By Ryan Davis ( December 10, 2012, 6:19 PM EST) -- A group of generics makers including Teva Pharmaceuticals USA Inc. urged the Federal Circuit on Friday to overturn a lower court's ruling that they infringed a patent for Pfizer Inc.'s blockbuster nerve pain drug Lyrica and that the patent is not obvious, claiming that the trial judge blindly adopted Pfizer's positions....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!